Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
ARA-290 Cibinetide
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Recovery & Reparación › ARA-290 Cibinetide
← Back to catalog Recovery & ReparaciónAvailable

ARA-290 Cibinetide (10 mg)

NeuroprotectorEPO-derivedNeuropathy
$135 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Erythropoietin-derived peptide without hematopoietic effects — neuroprotector and tissue repair agent with unique safety profile.

  • Mechanism: EPO-derived peptide that activates the innate repair receptor, without affecting hematocrit.
  • Evidence: Phase 2 human trials (small-fiber neuropathy, sarcoidosis, diabetic neuropathy).
  • In context: Investigational; generally well tolerated in trials.
Research range · SC
4 mg per application · once daily
🟢 Clinical evidence · Phase 2b

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundARA-290 Cibinetide
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC53H84N16O21
Molecular weight1257.3 g/mol
Sequence11-mer EPO-derived peptide
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

ARA-290 (Cibinetide): research profile

ARA-290, international nonproprietary name cibinetide, is a linear eleven-amino-acid peptide derived from helix B of erythropoietin (EPO). It was designed by Michael Brines and Anthony Cerami at Araim Pharmaceuticals to separate EPO's two functions: the hematopoietic one, which raises hematocrit and carries thrombotic risk, and the tissue-protective one. ARA-290 retains the second and leaves the first untouched, because it does not bind the classical homodimeric EPO receptor.

Its target is the so-called innate repair receptor, a heterodimer of one EPO-receptor subunit and the common β chain of the cytokine receptor (βcR), expressed only in tissues under damage or stress. Activating it attenuates local inflammation, reduces apoptosis and favors repair. Its plasma half-life is barely two minutes, yet the signal it triggers lasts hours, a singular pharmacological trait that shaped trial design.

It is one of the few catalog compounds with controlled clinical trials: Phase 2 in sarcoidosis-associated small fiber neuropathy (improved corneal nerve fiber density and symptoms) and in diabetic neuropathy, with good tolerability and no effect on hematocrit. It holds orphan-drug designation but no approval in any country. Renova distributes it for research only.

ARA-290 (Cibinetide) technical data

ClassNon-hematopoietic peptide derived from erythropoietin helix B
SequencepGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (11 aa; N-terminal pyroglutamate)
CAS1208243-50-8
NamesCibinetide (INN) · ARA 290 · pHBSP
TargetInnate repair receptor (EPOR–βcR); no affinity for the homodimeric EPOR
Half-life≈ 2 minutes in plasma; prolonged signaling effect
Clinical developmentPhase 2 in small fiber neuropathy (sarcoidosis) and diabetic neuropathy; orphan designation
Regulatory statusNot approved in any country

Questions about ARA-290 (Cibinetide)

Does ARA-290 raise red blood cells like erythropoietin?

No. It was designed precisely to avoid that: it does not bind the homodimeric EPO receptor that controls red-cell production, but a different receptor (EPOR–βcR) that appears only in damaged tissue. In clinical trials hematocrit did not change.

How can it act if its half-life is two minutes?

Because the signal it starts by activating the innate repair receptor persists for hours after the peptide has left the plasma. It is an example of a drug with very short pharmacokinetics and long pharmacodynamics; that is why trials evaluated it with once-daily administration.

What did the cibinetide clinical trials show?

In sarcoidosis-associated small fiber neuropathy, Phase 2 trials described increased corneal nerve fiber density and improved neuropathic symptoms versus placebo; in diabetic neuropathy, similar signals. Tolerability was good. No Phase 3 has been completed and there is no approval.

What does the “pGlu” at the start of the ARA-290 sequence mean?

It is a pyroglutamate: the N-terminal glutamate cyclized onto itself. That modification protects the end of the peptide from aminopeptidases and is part of the original design; without it the molecule would degrade even faster.

Related reading: ARA-290 (Cibinetide): The Innate Repair Receptor

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty